Theravance Biopharma, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG8807B1068
USD
18.70
0.27 (1.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
175.54
213.00
441.80
-338.57
-303.75
-223.84
Shareholder's Funds
175.54
213.00
441.80
-338.57
-303.75
-223.84
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
10.71
3.92
6.75
616.84
629.04
462.80
Secured Loans
10.71
3.92
6.75
616.84
629.04
462.80
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
75.20
65.29
64.19
0.24
0.00
0.00
Other Long Term Liabilities
146.53
144.24
136.88
55.41
49.4
75.77
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
146.53
144.24
136.88
654.81
649.24
520.96
Current Liabilities
Trade Payables
2.24
1.52
1.55
3.10
6.78
4.76
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
32.09
24.77
28.71
58.59
123.57
111.70
Total Liabilities
354.16
382.00
607.40
374.82
469.06
408.83
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
58.17
66.94
84.84
91.84
105.49
106.82
Less: Accumulated Depreciation
22.40
21.58
32.84
38.49
45.81
47.57
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
35.77
45.35
52.00
53.35
59.68
59.25
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
3.13
0.84
0.84
68.37
0.83
9.50
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
154.19
202.27
201.10
3.23
15.20
1.59
Total Non-Current Assets
193.09
248.46
253.94
124.95
75.72
70.34
Current Assets Loans & Advances
Current Investments
50.55
62.88
29.31
83.51
211.47
222.77
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
68.44
17.47
16.79
14.06
15.87
22.00
Cash and Bank
37.80
39.55
298.17
89.96
81.47
58.06
Other Current Assets
156.79
119.90
344.27
231.06
362.61
331.40
Short Term Loans and Advances
0.00
0.00
0.00
43.53
53.80
28.57
Total Current Assets
161.07
133.54
353.46
249.87
393.34
338.49
Net Current Assets (Including Current Investments)
128.98
108.77
324.75
191.28
269.77
226.78
Total Current Assets Excluding Current Investments
161.07
133.54
353.46
249.87
393.34
338.49
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
354.16
382.00
607.40
374.82
469.06
408.83
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
10.71
3.92
6.75
616.84
629.04
462.80
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 1.59% vs 5.38% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -21.12% vs -12.79% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 272.62% vs 0.00% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 20.62% vs -62.22% in Dec 2023

Compare Balance Sheet Results of Theravance Biopharma, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
175.54
155.55
19.99
12.85%
Shareholder's Funds
175.54
155.55
19.99
12.85%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
10.71
0.48
10.23
2,131.25%
Secured Loans
10.71
0.48
10.23
2,131.25%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
75.20
0
75.20
0.00%
Other Long Term Liabilities
146.53
33.18
113.35
341.62%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
146.53
33.18
113.35
341.62%
Current Liabilities
Trade Payables
2.24
4.69
-2.45
-52.24%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
32.09
31.60
0.49
1.55%
Total Liabilities
354.16
220.33
133.83
60.74%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
58.17
8.65
49.52
572.49%
Less: Accumulated Depreciation
22.40
4.80
17.60
366.67%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
35.77
3.85
31.92
829.09%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
3.13
90.30
-87.17
-96.53%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
154.19
0.22
153.97
69,986.36%
Total Non-Current Assets
193.09
94.38
98.71
104.59%
Current Assets Loans & Advances
Current Investments
50.55
89.02
-38.47
-43.22%
Inventories
0
0
0.00
0.00%
Sundry Debtors
68.44
0.32
68.12
21,287.50%
Cash and Bank
37.80
24.57
13.23
53.85%
Other Current Assets
156.79
113.91
42.88
37.64%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
161.07
125.95
35.12
27.88%
Net Current Assets (Including Current Investments)
128.98
94.35
34.63
36.70%
Total Current Assets Excluding Current Investments
161.07
125.95
35.12
27.88%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
354.16
220.33
133.83
60.74%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
10.71
0.48
10.23
2,131.25%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 146.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.59% vs 5.38% in Dec 2023

Annual - Fixed Assets
Fixed Assets 35.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -21.12% vs -12.79% in Dec 2023

Annual - Investments
Investments 3.13 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 272.62% vs 0.00% in Dec 2023

Annual - Current Assets
Current Assets 161.07 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.62% vs -62.22% in Dec 2023